SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-028845
Filing Date
2017-12-15
Accepted
2017-12-15 16:05:27
Documents
2
Period of Report
2017-12-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1611
2 EX-24 DOCUMENT attachment1.htm EX-24 4805
  Complete submission text file 0000899243-17-028845.txt   7786
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Issuer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address
Hunt Daniel W. (Reporting) CIK: 0001724058 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37719 | Film No.: 171259024